Hot Flashes

 

Hot flashes are caused by hormonal changes that interfere with your body’s ability to lower its temperature. If you’ve been treated for breast cancer or prostate cancer, your hormone levels have been affected, and there is a good chance that you will experience hot flashes at some point.

You’ll know you are having a hot flash because your face and upper body will get hot, red, and sweaty. Your heart will beat faster, dilating your blood vessels. This circulates more blood, which causes more heat. Your sweat glands then give off more perspiration in an effort to cool your body.

Sometimes chemotherapy causes sudden menopause (known as chemotherapy-induced menopause). This can bring on hot flashes. In addition, hormonal treatment of breast cancer with drugs, including tamoxifen, Arimidex® (anastrozole), or Femara® (letrozole) can also cause hot flashes. Men who are being treated with hormonal therapy for prostate cancer can also experience hot flashes. Lupron® and Eligard® (leuprolide), Zoladex® (goserelin), Trelstar® (triptorelin pamoate), and Vantas (histrelin)® are hormone-blocking medications that can cause hot flashes.

Tips for Managing Hot Flashes

  • Dress in layers of cotton clothing—daytime clothing and sleepwear.
  • Keep your home or workplace at a cool temperature.
  • Keep ice water handy.
  • Take a cool shower.
  • Try deep-breathing exercises.
  • Consider acupuncture or yoga.
  • Talk to your doctor about the medications Neurontin® (gabapentin), Effexor-XR® (venlafaxine), or Paxil® (paroxetine), or other drugs in the family of agents called SSRIs.
This content was last modified on February 08, 2008 .
Latest Cancer News
Vaccine Against HPV-16 Effective for Vulvar Intraepithelial Neoplasia

November 6, 2009 — Researchers from the Netherlands have reported that vaccination with synthetic long-peptides against human papillomavirus (HPV)-16 was effective in treating vulvar intraepithelial neoplasia (VIN). The details of this study were published in the November 5, 2009 issue of the New England Journal of Medicine.

Small HER2-positive Breast Cancers Have a Higher Risk of Recurrence

November 6, 2009 — Researchers from the M. D. Anderson Cancer Center and the University of Milan, Italy, have reported that women with Stage T1a,b, N0M0 HER2-positive breast cancers have a have a high recurrence rate without the administration of adjuvant chemotherapy or Herceptin® (trastuzumab). These data suggest that these women should be treated with Herceptin®-based adjuvant chemotherapy. The details of these two studies appeared in early online publications on November 2, 2009 in the Journal of Clinical Oncology.

Alcohol May Reduce Risk of Thyroid Cancer

November 6, 2009 — Researchers affiliated with the NIH-AARP Diet and Health Study have reported that alcohol intake may reduce the risk of thyroid cancer. The details of this study appeared in the November 4, 2009 issue of the British Journal of Cancer.

Select news items provided by Reuters Health